We are live on ! Find out more
BDF

Balasa Dinverno & Foltz Portfolio holdings

AUM $1.58B
1-Year Est. Return 17.55%
This Fund
S&P 500
This Quarter Est. Return
-5.84%
1 Year Est. Return
-17.55%
3 Year Est. Return
+23.2%
5 Year Est. Return
+47.16%
10 Year Est. Return
AUM
$1.48B
AUM Growth
-$69.7M
Cap. Flow
+$31.6M
Cap. Flow %
2.13%
Top 10 Hldgs %
58.13%
Holding
369
New
26
Increased
124
Reduced
166
Closed
25

Sector Composition

Rank Sector Weight
1 Technology 7.25%
2 Healthcare 3.98%
3 Financials 3.69%
4 Consumer Staples 2.35%
5 Consumer Discretionary 2.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AL
126
DELISTED
Air Lease Corp
AL
$1.07M 0.07%
24,023
-1,337
-5% -$56K
AN icon
127
AutoNation
AN
$6.88B
$1.06M 0.07%
10,697
+542
+5% +$59.9K
IWB icon
128
iShares Russell 1000 ETF
IWB
$50.1B
$1.05M 0.07%
4,205
-227
-5% -$56K
ADM icon
129
Archer Daniels Midland
ADM
$38.4B
$1.05M 0.07%
11,615
+1,238
+12% +$96.4K
NULG icon
130
Nuveen ESG Large-Cap Growth ETF
NULG
$2.79B
$1.04M 0.07%
17,179
+2,144
+14% +$128K
GEN icon
131
Gen Digital
GEN
$17B
$1.04M 0.07%
39,061
+611
+2% +$16.8K
CWI icon
132
State Street SPDR MSCI ACWI ex-US ETF
CWI
$2.87B
$1.03M 0.07%
37,293
-3,161
-8% -$88.9K
CMC icon
133
Commercial Metals
CMC
$7.93B
$1.02M 0.07%
24,424
-344
-1% -$12.9K
T icon
134
AT&T
T
$168B
$1.01M 0.07%
56,658
+20,129
+55% +$372K
NEM icon
135
Newmont
NEM
$127B
$1M 0.07%
12,590
-398
-3% -$26.9K
ED icon
136
Consolidated Edison
ED
$40B
$972K 0.07%
10,270
+524
+5% +$45.3K
HZNP
137
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$931K 0.06%
8,852
-894
-9% -$87.1K
EXC icon
138
Exelon
EXC
$46.4B
$912K 0.06%
19,140
-4,927
-20% -$209K
MRO
139
DELISTED
Marathon Oil Corporation
MRO
$890K 0.06%
35,444
+21,248
+150% +$456K
MSCI icon
140
MSCI
MSCI
$40.8B
$871K 0.06%
1,733
UNP icon
141
Union Pacific
UNP
$174B
$867K 0.06%
3,175
+101
+3% +$25.5K
GS icon
142
Goldman Sachs
GS
$305B
$839K 0.06%
2,541
-344
-12% -$121K
LBRDK icon
143
Liberty Broadband Class C
LBRDK
$5.09B
$828K 0.06%
6,116
-99
-2% -$14.4K
EW icon
144
Edwards Lifesciences
EW
$53.2B
$824K 0.06%
7,001
+706
+11% +$79.2K
BHF icon
145
Brighthouse Financial
BHF
$3.41B
$818K 0.06%
15,825
-616
-4% -$32.9K
CNXC icon
146
Concentrix
CNXC
$1.51B
$816K 0.06%
4,902
-8
-0.2% -$1.52K
HON icon
147
Honeywell
HON
$73.5B
$811K 0.05%
4,423
-234
-5% -$43.3K
DUK icon
148
Duke Energy
DUK
$96.3B
$799K 0.05%
7,155
-668
-9% -$69.4K
LDEM icon
149
iShares ESG MSCI EM Leaders ETF
LDEM
$33.2M
$799K 0.05%
14,837
+7,154
+93% +$400K
TMHC
150
DELISTED
Taylor Morrison
TMHC
$795K 0.05%
29,194
+1,368
+5% +$41.6K

Similar funds

Balasa Dinverno & Foltz's Q1 2022 Portfolio in Review

As of Q1 2022, Balasa Dinverno & Foltz held 369 positions worth $1.48B, down 4.5% from $1.55B the previous quarter. Its ten largest holdings account for 58% of the portfolio.

Balasa Dinverno & Foltz's Q1 2022 filing shows 26 new, 124 increased, 166 reduced and 25 closed positions. Its largest new stake was iShares National Muni Bond ETF: 151,894 shares worth $16.7M. The largest sale was iShares Russell Mid-Cap Growth ETF, an estimated $14.1M.

By sector, the portfolio is most concentrated in Technology at 7.2% of assets, down from 7.6% a quarter earlier, followed by Healthcare and Financials.

  • Balasa Dinverno & Foltz's largest Q1 2022 buy was iShares National Muni Bond ETF: 151,894 shares worth $16.7M.
  • Balasa Dinverno & Foltz added most to Vanguard Morningstar Small-Cap Growth ETF in Q1 2022, an estimated $4.28M increase.
  • Balasa Dinverno & Foltz's biggest Q1 2022 reduction was iShares Russell 1000 Growth ETF, cutting an estimated $1.88M.
  • Balasa Dinverno & Foltz fully exited iShares Russell Mid-Cap Growth ETF in Q1 2022, selling an estimated $14.1M.
  • Balasa Dinverno & Foltz's ten largest holdings make up 58% of its $1.48B portfolio in Q1 2022.
  • Balasa Dinverno & Foltz opened 26 new positions and closed 25 in Q1 2022.
  • Balasa Dinverno & Foltz's portfolio value fell 4.5% quarter-over-quarter to $1.48B.

Based on Balasa Dinverno & Foltz's 13F filing for Q1 2022, filed 25 Apr 2022.